Journal of Clinical Medicine (Jun 2019)

A Novel Pathogenic Variant in <i>MT-CO2</i> Causes an Isolated Mitochondrial Complex IV Deficiency and Late-Onset Cerebellar Ataxia

  • Charlotte M. Zierz,
  • Karen Baty,
  • Emma L. Blakely,
  • Sila Hopton,
  • Gavin Falkous,
  • Andrew M. Schaefer,
  • Marios Hadjivassiliou,
  • Ptolemaios G. Sarrigiannis,
  • Yi Shiau Ng,
  • Robert W. Taylor

DOI
https://doi.org/10.3390/jcm8060789
Journal volume & issue
Vol. 8, no. 6
p. 789

Abstract

Read online

Both nuclear and mitochondrial DNA defects can cause isolated cytochrome c oxidase (COX; complex IV) deficiency, leading to the development of the mitochondrial disease. We report a 52-year-old female patient who presented with a late-onset, progressive cerebellar ataxia, tremor and axonal neuropathy. No family history of neurological disorder was reported. Although her muscle biopsy demonstrated a significant COX deficiency, there was no clinical and electromyographical evidence of myopathy. Electrophysiological studies identified low frequency sinusoidal postural tremor at 3 Hz, corroborating the clinical finding of cerebellar dysfunction. Complete sequencing of the mitochondrial DNA genome in muscle identified a novel MT-CO2 variant, m.8163A>G predicting p.(Tyr193Cys). We present several lines of evidence, in proving the pathogenicity of this heteroplasmic mitochondrial DNA variant, as the cause of her clinical presentation. Our findings serve as an important reminder that full mitochondrial DNA analysis should be included in the diagnostic pipeline for investigating individuals with spinocerebellar ataxia.

Keywords